These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2507191

  • 1. Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters.
    Sharkey NA, Hennings H, Yuspa SH, Blumberg PM.
    Carcinogenesis; 1989 Oct; 10(10):1937-41. PubMed ID: 2507191
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
    Ewing MW, Crysup SE, Phillips JL, Slaga TJ, DiGiovanni J.
    Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
    [Abstract] [Full Text] [Related]

  • 3. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW, Conti CJ, Phillips JL, Slaga TJ, DiGiovanni J.
    J Natl Cancer Inst; 1989 May 03; 81(9):676-82. PubMed ID: 2496233
    [Abstract] [Full Text] [Related]

  • 4. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
    Verma AK.
    Cancer Res; 1988 Apr 01; 48(7):1736-9. PubMed ID: 3127039
    [Abstract] [Full Text] [Related]

  • 5. Critical comparison of histological and morphometric changes in SENCAR mouse epidermis in response to n-dodecane, 12-O-tetradecanoylphorbol-13-acetate and mezerein.
    Miller ML, Andringa A, Baxter CS.
    Carcinogenesis; 1988 Nov 01; 9(11):1959-65. PubMed ID: 3180333
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate.
    Gilmour SK, Robertson FM, Megosh L, O'Connell SM, Mitchell J, O'Brien TG.
    Carcinogenesis; 1992 Jan 01; 13(1):51-6. PubMed ID: 1733573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Skin carcinomas and micronucleus induction in epidermal keratinocytes following 12-O-tetradecanoylphorbol-13-acetate and mezerein treatment.
    Steinel HH, Bonin AM, Meher-Homji K, Baker RS.
    Mutagenesis; 1992 May 01; 7(3):199-203. PubMed ID: 1602975
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters.
    Fischer SM, O'Connell JF, Conti CJ, Tacker KC, Fries JW, Patrick KE, Adams LM, Slaga TJ.
    Carcinogenesis; 1987 Mar 01; 8(3):421-4. PubMed ID: 3545526
    [Abstract] [Full Text] [Related]

  • 19. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
    Abdel-Fattah R, Glick A, Rehman I, Maiberger P, Hennings H.
    Int J Cancer; 2006 Feb 01; 118(3):527-31. PubMed ID: 16094607
    [Abstract] [Full Text] [Related]

  • 20. Comparative histomorphometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents.
    Baxter CS, Andringa A, Chalfin K, Miller ML.
    Carcinogenesis; 1989 Oct 01; 10(10):1855-61. PubMed ID: 2791204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.